NYSEARCA:ELMD • US2854091087
The current stock price of ELMD is 24.1 USD. In the past month the price decreased by -19.32%. In the past year, price decreased by -5.23%.
ChartMill assigns a fundamental rating of 7 / 10 to ELMD. ELMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months ELMD reported a non-GAAP Earnings per Share(EPS) of 1.03. The EPS increased by 37.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.38% | ||
| ROA | 15.29% | ||
| ROE | 18.32% | ||
| Debt/Equity | 0 |
10 analysts have analysed ELMD and the average price target is 37.4 USD. This implies a price increase of 55.19% is expected in the next year compared to the current price of 24.1.
For the next year, analysts expect an EPS growth of 28.75% and a revenue growth 14.79% for ELMD
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.87 | 202.318B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.55 | 178.812B | ||
| SYK | STRYKER CORP | 25.6 | 148.172B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.76 | 113.97B | ||
| IDXX | IDEXX LABORATORIES INC | 42.97 | 52.44B | ||
| BDX | BECTON DICKINSON AND CO | 11.2 | 50.281B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.32 | 50.178B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.96 | 38.406B | ||
| RMD | RESMED INC | 20.96 | 37.332B | ||
| DXCM | DEXCOM INC | 29.22 | 28.639B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED INC
500 Sixth Avenue Nw
New Prague MINNESOTA 56071 US
CEO: Kathleen S. Skarvan
Employees: 174
Phone: 19527589299
Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
The current stock price of ELMD is 24.1 USD. The price increased by 1.69% in the last trading session.
ELMD does not pay a dividend.
ELMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
10 analysts have analysed ELMD and the average price target is 37.4 USD. This implies a price increase of 55.19% is expected in the next year compared to the current price of 24.1.
The Revenue of ELECTROMED INC (ELMD) is expected to grow by 14.79% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.